Index Entries

Liguo Zhang, Alexsia Richards, M. Inmaculada Barrasa, Stephen H. Hughes, Richard A. Young, and Rudolf Jaenisch
May 25, 2021
Proceedings of the National Academy of Sciences
National Academy of Sciences

Significance: An unresolved issue of SARS-CoV-2 disease is that patients often remain positive for viral RNA as detected by PCR many weeks after the initial infection in the absence of evidence for viral replication. We show here that SARS-CoV-2 RNA can be reverse-transcribed and integrated into the genome of the infected cell and be expressed as chimeric transcripts fusing viral with cellular sequences. Importantly, such chimeric transcripts are detected in patient-derived tissues. Our data suggest that, in some patient tissues, the majority of all viral transcripts are derived from integrated sequences. Our data provide an insight into the consequence of SARS-CoV-2 infections that may help to explain why patients can continue to produce viral RNA after recovery.”

Response by Rhys Parry, et al., August 3, 2021: https://www.pnas.org/content/118/33/e2109066118 Response to Parry, et al., by Zhang, Richards, et al., August 17, 2021: https://www.pnas.org/content/118/33/e2109497118

document
COVID-19,vaccine composition,vaccine dynamics,FDA approvals,manufacturers,vaccines,reverse transcription